test3

Attention Virginia Cancer Specialists Patients: There is a system outage and certain functions, such as scheduling, may not be available today. We will call patients to schedule any upcoming appointments when the system is back online. Our clinics remain open and previously scheduled appointments will continue as planned. We apologize for any inconvenience.

 

Immunotherapy Cancer Treatment - Exciting new area for oncology

Virginia Cancer Specialists Practice Blog

August 29, 2016
Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » VCS Practice News » The Research Institute » Immunotherapy Cancer Treatment – Exciting new area for oncology

Immunotherapy has proven to be one of the most exciting new areas for oncology and for our patients.

These drugs have proven to be very effective in certain cancers (e.g. melanoma, lung cancer) but not in all. VCS is excited to open several new clinical trials using immunotherapy for patients that have either failed prior immunotherapy drugs or are interested in this approach for their cancers.

Currently we have several studies open across many tumor types using this approach.

In addition, we have other studies as well at other novel therapeutics as well for patients looking to explore treatments different than the standard, or looking for alternatives to standard chemotherapy. VCS currently runs a Phase 1 clinic with access to physicians with expertise in novel therapeutics, clinical trials, and personalized/genomic approaches to their care.

Alex Spira, MD, PhD, FACP

Alex Spira, M.D., PhD, F.A.C.P.

Clinical Trials and Research at Virginia Cancer Specialists

Immuno-Oncology

Schedule An Appointment Here